Baudax Bio, Inc. (BXRX)

HEALTH CARE: PHARMACEUTICALS
SIC: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC

490 LAPP ROAD MALVERN, PA 19355

Baudax Bio is a pharmaceutical company focused on therapeutics for acute care settings. The launch of Baudax Bio's first commercial product ANJESO® began in June 2020 following its approval by the U.S. Food and Drug Administration in February 2020. ANJESO is a once daily IV NSAID with preferential Cox-2 activity, which has successfully completed three Phase III clinical trials, including two pivotal efficacy trials, a large double-blind Phase III safety trial and other studies for the management of moderate to severe pain. In addition to ANJESO, Baudax Bio has a pipeline of other pharmaceutical assets including two novel neuromuscular blocking agents (NMBAs) and a proprietary chemical reversal agent specific to these NMBAs which is currently in preclinical studies, and intranasal dexmedetomidine which is being developed for possible uses in pain or sedation.

Data as of 2021-06-19 12:49:08 -0400
Market Cap54.819 Million Shares Outstanding70.245 Million Avg 30-day Volume2.122 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.98 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.44308 52-week High/Low4.73 / 0.75 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from BXRX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 38 38 0.0% 13 (0.76%) 17 (0.99%) -23.53%
13F shares: 7.308 Million 6.277 Million 16.42% 1.35 Million 5.187 Million -73.97%
% Ownership 10.4182 14.7209 -29.23% 1.9246 12.165 -84.18%
New Positions: 11 12 -8.33% 2 6 -66.67%
Increased Positions 10 12 -16.67% 5 4 25.0%
Closed Positions 11 7 57.14% 6 2 200.0%
Reduced Positions 7 7 0.0% 3 4 -25.0%
Total Calls 656.118 Thousand 101.2 Thousand 548.34% 130.3 Thousand 84.5 Thousand 54.2%
Total Puts 77.644 Thousand 27.018 Thousand 187.38% 0
PUT/CALL Ratio 0.12 0.27 -55.56% 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BXRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BXRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

66 Thousand total shares from 5 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CHURCHILL WINSTON J

  • Director
163,685 2021-06-07 2

CASTEN RICHARD S CHIEF FINANCIAL OFFICER

  • Officer
150,000 2021-05-14 4

BASKIES ARNOLD M

  • Director
86,452 2021-05-11 4

HENWOOD GERALDINE PRESIDENT AND CEO

  • Officer
  • Director
376,307 2021-05-07 3

ALTOMARI ALFRED

  • Director
201,118 2021-04-07 2

ASHTON WILLIAM

  • Director
190,518 2021-04-07 1

WEISMAN WAYNE

  • Director
203,318 2021-04-07 1

DRECHSLER ANDREW T

  • Director
159,785 2021-04-07 3

LAKE RYAN DAVID CHIEF FINANCIAL OFFICER

  • Officer
69,251 2021-01-15 2

RECRO PHARMA, INC.

  • 10% Owner
0 2019-11-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CHURCHILL WINSTON J - Director

2021-06-08 16:14:10 -0400 2021-06-07 P 10,000 $0.78 a 157,185 direct -3.5294 -7.5294 0.0 1 -7.5294 6

CHURCHILL WINSTON J - Director

2021-06-08 16:14:10 -0400 2021-06-07 P 15,000 $0.78 a 147,185 direct -3.5294 -7.5294 0.0 1 -7.5294 6

CASTEN RICHARD S - Officer CHIEF FINANCIAL OFFICER

2021-05-17 16:35:27 -0400 2021-05-14 P 25,000 $0.79 a 150,000 direct -2.809 -5.618 0.0 1 -5.618 6

BASKIES ARNOLD M - Director

2021-05-13 17:32:05 -0400 2021-05-11 P 10,000 $0.82 a 86,452 direct 3.4568 5.0617 9.8765 3 0.0 1

HENWOOD GERALDINE - Director - Officer PRESIDENT AND CEO

2021-05-10 16:12:18 -0400 2021-05-07 P 6,000 $0.83 a 356,307 direct -2.5579 8.4044 8.4044 6 -6.821 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BAUDAX BIO INC BXRX 2021-06-18 22:15:03 UTC -12.9308 13.0108 4800000
BAUDAX BIO INC BXRX 2021-06-18 21:45:03 UTC -12.9308 13.0108 4800000
BAUDAX BIO INC BXRX 2021-06-18 21:15:03 UTC -12.9308 13.0108 4800000
BAUDAX BIO INC BXRX 2021-06-18 20:45:03 UTC -12.9308 13.0108 4800000
BAUDAX BIO INC BXRX 2021-06-18 20:15:04 UTC -12.9308 13.0108 4800000
BAUDAX BIO INC BXRX 2021-06-18 19:45:03 UTC -12.9308 13.0108 4800000
BAUDAX BIO INC BXRX 2021-06-18 19:15:03 UTC -12.9308 13.0108 4800000
BAUDAX BIO INC BXRX 2021-06-18 18:45:03 UTC -12.9308 13.0108 4800000
BAUDAX BIO INC BXRX 2021-06-18 18:15:02 UTC -12.9308 13.0108 4800000
BAUDAX BIO INC BXRX 2021-06-18 17:45:03 UTC -12.9275 12.9675 4800000
BAUDAX BIO INC BXRX 2021-06-18 17:15:03 UTC -12.9275 12.9675 4800000
BAUDAX BIO INC BXRX 2021-06-18 16:45:03 UTC -12.9275 12.9675 4800000
BAUDAX BIO INC BXRX 2021-06-18 16:15:03 UTC -12.9275 12.9675 4800000
BAUDAX BIO INC BXRX 2021-06-18 15:45:03 UTC -12.9275 12.9675 4800000
BAUDAX BIO INC BXRX 2021-06-18 15:15:03 UTC -12.9275 12.9675 4800000
BAUDAX BIO INC BXRX 2021-06-18 14:45:03 UTC -12.9275 12.9675 4800000
BAUDAX BIO INC BXRX 2021-06-18 14:15:03 UTC -12.9275 12.9675 4800000
BAUDAX BIO INC BXRX 2021-06-18 13:45:03 UTC -12.9275 12.9675 4800000
BAUDAX BIO INC BXRX 2021-06-18 13:15:03 UTC -12.9275 12.9675 4800000
BAUDAX BIO INC BXRX 2021-06-18 12:45:03 UTC -12.9275 12.9675 4800000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments